298 studies found for:    HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
Conditions: HIV-1 Infection;   Treatment Resistant Disorders;   Viremia
Interventions: Drug: Protease inhibitor;   Drug: Isentress® (raltegravir);   Other: Counseling arm
22 Recruiting Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial
Conditions: HIV;   Addiction
Intervention: Other: Integrated methadone and antiretroviral therapy (iMART) clinic
23 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
24 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
25 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
26 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
27 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
28 Unknown  High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Conditions: HIV;   AIDS
Intervention: Drug: Kaletra (drug)
29 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
30 Recruiting Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
Condition: Human Immunodeficiency Virus
Interventions: Drug: Raltegravir;   Drug: Dolutegravir;   Procedure: Colonoscopy with biopsy
31 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
32 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
33 Recruiting PrEP Demonstration Project (PRELUDE Study)
Condition: HIV
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
34 Not yet recruiting IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants
Conditions: Low-Birth-Weight Infant;   Tuberculosis;   HIV
Intervention:
35 Not yet recruiting Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers
Conditions: HIV;   Hepatitis C
Interventions: Drug: dolutegravir;   Drug: simeprevir
36 Recruiting Pharmacokinetic (PK) Characteristics and Anti-Inflammatory Effects of the NK-1R Antagonist, Aprepitant, In HIV-Infected Subjects With Undetectable Viral Load Receiving Atazanavir/Ritonavir Or Darunavir/Ritonavir-Containing Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Aprepitant
37 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
38 Recruiting Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
39 Not yet recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
40 Unknown  Nelfinavir and M8 Drug-Level Monitoring in HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Nelfinavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years